• About
  • FinancialVu Network
  • Register
  • Log In

FinancialVu

Market News and Views

  • Home
  • Commodities
  • Economics
  • Personal Finance
  • Other Articles
  • Reading List
  • Resources
You are here: Home / Archives for MarketWatch.com - Top Stories

: Biden administration considers crackdown on AI tools such as ChatGPT

April 11, 2023 by MarketWatch.com - Top Stories

The Biden administration is edging toward rules on AI tools such as ChatGPT over fears the technology could be used to spread falsehoods and discrimination.

Filed Under: Top Stories

Currencies: How a decelerating U.S. economy could impact rest of world, putting spotlight on the dollar

April 11, 2023 by MarketWatch.com - Top Stories

Investors, traders and strategists are weighing the potential ramifications of a slowing U.S. economy on the rest of the world.

Filed Under: Top Stories

: Here’s how much NFL Sunday Ticket will cost on YouTube TV this season

April 11, 2023 by MarketWatch.com - Top Stories

YouTube TV subscribers can get a premium $389-a-year plan that also includes the NFL’s popular RedZone channel. For nonsubscribers, that will cost $489.

Filed Under: Top Stories

Deep Dive: This small-cap stock fund shows how you can get your money’s worth paying for active management

April 11, 2023 by MarketWatch.com - Top Stories

Actively managed stock funds can be highly differentiated from indexes, and the SouthernSun Small Cap Fund is a good example.

Filed Under: Top Stories

: Weight Watchers parent’s stock soars after ‘game-changer’ deal to buy weight-loss drug prescriber Sequence closes

April 11, 2023 by MarketWatch.com - Top Stories

WW International’s stock soared Tuesday after the Weight Watchers parent said the deal to buy telehealth company Sequence has been completed.

Filed Under: Top Stories

: Moderna is developing a vaccine against the tick-borne Lyme disease, in a first for the company

April 11, 2023 by MarketWatch.com - Top Stories

Moderna Inc. said Tuesday that it’s working to develop its first bacterial vaccine to protect against Lyme disease.

Filed Under: Top Stories

: Good news for credit scores: 70% of medical debt has been removed from U.S. consumers’ credit reports

April 11, 2023 by MarketWatch.com - Top Stories

‘We understand that medical debt is generally not taken on voluntarily,’ the CEOs of Equifax, Experian, and TransUnion said in a joint statement.

Filed Under: Top Stories

: Credit crunch could lower U.S. GDP by half-percentage point over the next year, IMF says

April 11, 2023 by MarketWatch.com - Top Stories

The recent stress in the banking sector could reduce the ability of U.S. banks to lend over the next year, and materially lower U.S. economic growth, the International Monetary Fund said Tuesday.

Filed Under: Top Stories

: Too soon to know if recent bank troubles are isolated events, IMF says

April 11, 2023 by MarketWatch.com - Top Stories

It is too soon to know for sure whether the recent bank troubles were isolated or a harbinger of future events, the IMF said Tuesday.

Filed Under: Top Stories

: This is what led to the Rutgers strike as a wave of activism hits colleges 

April 11, 2023 by MarketWatch.com - Top Stories

Increasing reliance on adjunct professors and graduate students is pushing college employees fed up with the status quo

Filed Under: Top Stories

  • « Previous Page
  • 1
  • …
  • 819
  • 820
  • 821
  • 822
  • 823
  • …
  • 1275
  • Next Page »

Recent Articles

Starboard may be poised to build value amicably at contract research firm Fortrea

Activist Starboard Value recently disclosed a position in Fortrea Holdings. The … [Read More...]

  • High rates are historically bad for bitcoin. Here’s what’s in store for crypto with the 10-year near 5%
  • Stocks like Nvidia have ‘earnings upside’ ahead of quarterly reports, Wall Street analysts say
  • Israel-Hamas war live updates: First aid trucks enter Gaza from Egypt; Palestinian leader says ‘we will remain on our land’

Follow Us Online

  • Twitter

Copyright © 2026 · News Pro Theme on Genesis Framework · WordPress · Log in